{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:43:57Z","timestamp":1780721037786,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":480,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD39005"],"award-info":[{"award-number":["U10 HD39005"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54-HD29834"],"award-info":[{"award-number":["U54-HD29834"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD38992"],"award-info":[{"award-number":["U10 HD38992"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD055936"],"award-info":[{"award-number":["U10 HD055936"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD055944"],"award-info":[{"award-number":["U10 HD055944"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10HD055925"],"award-info":[{"award-number":["U10HD055925"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD27049"],"award-info":[{"award-number":["U10 HD27049"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD38998"],"award-info":[{"award-number":["U10 HD38998"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD055942"],"award-info":[{"award-number":["U10 HD055942"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10HD03005-0851"],"award-info":[{"award-number":["U10HD03005-0851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000127"],"award-info":[{"award-number":["UL1 TR000127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD055944"],"award-info":[{"award-number":["HD055944"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10HD055925-02W1"],"award-info":[{"award-number":["U10HD055925-02W1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10 U54-HD29834"],"award-info":[{"award-number":["U10 U54-HD29834"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.fertnstert.2020.06.015","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T10:56:57Z","timestamp":1598957817000},"page":"438-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Highly elevated level of antim\u00fcllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-259X","authenticated-orcid":false,"given":"Amy","family":"Kaing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni A.","family":"Jaswa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Legro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle I.","family":"Cedars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather G.","family":"Huddleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2020.06.015_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jwh.2014.5000","article-title":"Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study","volume":"24","author":"Joham","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cct.2011.12.005","article-title":"The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome","volume":"33","author":"Legro","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib7","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/humrep\/deq100","article-title":"PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene","volume":"25","author":"Johnson","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ajog.2004.05.030","article-title":"Does metformin induce ovulation in normoandrogenic anovulatory women?","volume":"191","author":"Carmina","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1471-0528.12558","article-title":"Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia","volume":"121","author":"Naver","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib13","first-page":"1","article-title":"Births in the United States, 2017","author":"Martin","year":"2018","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/jp.2011.194","article-title":"Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome","volume":"32","author":"Yamamoto","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053801","article-title":"Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration","volume":"8","author":"Galazis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3181\/00379727-66-16071","article-title":"The age factor in the castration of male rabbit fetuses","volume":"66","author":"Jost","year":"1947","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib18","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/en.2005-1588","article-title":"Serum anti-Mullerian hormone levels reflect the size of the primordial follicle pool in mice","volume":"147","author":"Kevenaar","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib19","first-page":"3836","article-title":"Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib20","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/jc.2018-01320","article-title":"Mullerian-inhibiting substance\/anti-Mullerian hormone as a predictor of preterm birth in polycystic ovary syndrome","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.fertnstert.2019.09.039","article-title":"High antimullerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome","volume":"113","author":"Hu","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/humrep\/deu036","article-title":"A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay","volume":"29","author":"Welsh","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/AOG.0000000000003084","article-title":"ACOG committee opinion no. 764 summary: medically indicated late-preterm and early-term deliveries","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2018-01787","article-title":"Pre-conception characteristics predict obstetrical and neonatal outcomes in women with polycystic ovary syndrome","volume":"104","author":"Christ","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/aogs.12545","article-title":"Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes","volume":"94","author":"Mumm","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib30","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonzalez","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib32","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1210\/jc.2019-00383","article-title":"A narrative review of placental contribution to adverse pregnancy outcomes in women with polycystic ovary syndrome","volume":"104","author":"Kelley","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1055\/s-0036-1572434","article-title":"Maternal and perinatal outcomes in women with insulin resistance","volume":"33","author":"Temming","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Lovvik","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib35","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/humrep\/del185","article-title":"Metformin treatment is effective in obese teenage girls with PCOS","volume":"21","author":"De Leo","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"De Leo","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2008.01.028","article-title":"Evidence for a Mullerian-inhibiting substance autocrine\/paracrine system in adult human endometrium","volume":"91","author":"Wang","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib39","first-page":"532","article-title":"Mullerian inhibiting substance\/anti-Mullerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria","volume":"17","author":"Kim","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib40","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/mrd.20858","article-title":"A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice","volume":"75","author":"Arango","year":"2008","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5468\/ogs.2018.61.1.127","article-title":"The expression of Mullerian inhibiting substance\/anti-Mullerian hormone type II receptor in myoma and adenomyosis","volume":"61","author":"Kim","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib42","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/labinvest.2011.116","article-title":"Anti-Mullerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis","volume":"91","author":"Anttonen","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061325","article-title":"Anti-Mullerian hormone expression in endometrial cancer tissue","volume":"20","author":"Gowkielewicz","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib44","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejogrb.2009.02.044","article-title":"Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour","volume":"144(Suppl 1)","author":"Shynlova","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12958-015-0082-4","article-title":"Anti-Mullerian-hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay","volume":"13","author":"Koninger","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib46","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1002\/hsr2.53","article-title":"A pilot longitudinal study of anti-Mullerian hormone levels throughout gestation in low risk pregnancy","volume":"1","author":"Freeman","year":"2018","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib47","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.fertnstert.2015.04.044","article-title":"Changes in antimullerian hormone levels in early pregnancy are associated with preterm birth","volume":"104","author":"Stegmann","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.06.015_bib49","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2018.11.028","article-title":"Circulating antimullerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term","volume":"111","author":"Piltonen","year":"2019","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220305872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220305872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:28:36Z","timestamp":1758011316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028220305872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0015028220305872"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.06.015","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly elevated level of antim\u00fcllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}